02 May 2017
Washington DC
Reporter: Barney Dixon

Federal Circuit defines AIA on-sale bar provision


The America Invents Act’s (AIA) on-sale bar provision renders a patent invalid if the invention is sold before the filing date, according to the US Court of Appeals for the Federal Circuit.

Helsinn Healthcare brought the case against Teva Pharmaceuticals, alleging the infringement of four patents relating to medication for reducing nausea and vomiting during chemotherapy.

Teva responded on the grounds that the patents were invalid under the on-sale bar provision of the AIA.

The US District Court for the District of New Jersey disagreed with this argument in its decision.

But on appeal, the Federal Circuit reversed this ruling, stating that the claims of the patents were “subject to an invalidation contract for sale prior to the critical date of 30 January 2002”, and that the “AIA did not change the statutory meaning of ‘on sale’ in the circumstances involved here”.

“The asserted claims were also ready for patenting prior to the critical date.”

If over a year before a patent’s filing date, a sales offer still acts as a bar to a patent, even if the sale is not public.

Matthew Siegal, partner at Stroock & Stroock & Lavan, said: “While the decision is correct, it omits a discussion of the reasoning behind the on-sale bar, so as to ascertain the spirit of the law.”

“Patentees are precluded from extending the term of their patent. If they can begin soliciting offers for the patented goods more than a year before the filing date, they can artificially extend their 20 year.”

More news
The latest news from IPPro Patents
Join Our Newsletter

Sign up today and never
miss the latest news or an issue again

Subscribe now
Patent owners winning in IPR
12 December 2017 | New York | Reporter: Barney Dixon
Patent owners are winning more than losing in IPR proceedings, according to a study from law firm Fitzpatrick, Cella, Harper & Scinto
High tech companies weigh in on Allergan deal
11 December 2017 | Washington DC | Reporter: Barney Dixon
Tech companies have argued that Allergan should not be allowed to circumvent the inter partes review process with its controversial patent deal with the Saint Regis Mohawk Tribe
BlackBerry to pay $137 million to Nokia
08 December 2017 | Waterloo | Reporter: Barney Dixon
BlackBerry will pay $137 million to Nokia after the International Chamber of Commerce’s International Court of Arbitration ruled against the company in a patent licensing dispute
ILO ruling “vote of no confidence” for Battistelli, says CSC
07 December 2017 | Munich | Reporter: Barney Dixon
In an open letter to the EPO’s heads of delegations, the CSC said that it interpreted the ILO’s decision as a “massive vote of no confidence in the president of the EPO"
China world’s top patent filer in 2016
07 December 2017 | Geneva | Reporter: Barney Dixon
China has emerged as the top patent filer in the world, accounting for nearly all of the 8 percent growth in patent applications in 2016
EPO president’s impartiality questioned at ILO
06 December 2017 | Geneva | Reporter: Barney Dixon
The International Labour Organisation has questioned the impartiality of EPO president Benoît Battistelli, in two tribunal decisions concerning an EPO employee, and found that there was a conflict of interest on the part of the president
Squire Patton Boggs hires ex Walgreens Boots Alliance counsel
06 December 2017 | London | Reporter: Barney Dixon
Squire Patton Boggs has appointed Kerry Lee as partner in its intellectual property and technology practice